"Promising New Drug Offers Hope for Mesothelioma Treatment Breakthrough"
TL;DR Summary
Scientists at Queen Mary University in the UK have developed a new drug, ADI-PEG20, which has shown promising results in treating mesothelioma, a deadly cancer caused by asbestos exposure. The drug, which works by cutting off the tumor's food supply, has quadrupled three-year survival rates and increased average survival by 1.6 months. This breakthrough marks the first successful combination of chemotherapy with a drug that targets cancer's metabolism for this disease in 20 years, offering hope for improved treatment outcomes for mesothelioma patients.
- UK Scientists Develop New "Wonder" Drug That Offers Breakthrough Treatment Of Deadly Cancer NDTV
- Mesothelioma Patients' Survival Rates Boosted by Trial Mirage News
- Drug breakthrough for asbestos-linked cancer treatment The Times
- New Treatment Brings Hope for Rare, Deadly Cancer Linked to Asbestos U.S. News & World Report
- Mesothelioma Treatment: What You Need to Know about Nivolumab and Ipilimumab Surviving Mesothelioma
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
2 min
vs 3 min read
Condensed
83%
499 → 83 words
Want the full story? Read the original article
Read on NDTV